[Joint Letter from 12 American NGOs] We write as American organizations in advance of your trip to India this month to ask you to support India’s central role in providing high-quality, low-cost generic medicines—which are essential for health care around the world. Recent U.S. policy stances have sought to topple parts of India’s intellectual property regime that protect public health in order to advance the interests of multinational pharmaceutical corporations in longer, stronger, and broader exclusive patent and related monopoly rights. India’s laws fully comply with the WTO TRIPS Agreement. Millions around the world depend on affordable generic medicines that would disappear if India acceded to these proposals, including many beneficiaries of US-funded programs. Instead of using your trip to promote the narrow interests of one segment of the pharmaceutical industry, we ask you to support the interests of people who need affordable medicines, whether they live in the U.S., in India, in Africa or elsewhere. Our world is safer and healthier because of India’s pro-health stance and we ask you to say so publicly while you are there.
Follow
Free to Share
Comments on:
- An error has occurred, which probably means the feed is down. Try again later.
Civil Society Documents
- An error has occurred, which probably means the feed is down. Try again later.
Comments on:
- An error has occurred, which probably means the feed is down. Try again later.
industry | infojustice
- Aspen Doesn’t Want You to Own Your Own Casebooks
- Still Profitable After All These Years
- Recording Industry Reports Growth from User-Generated Content and New Projects in Emerging Economies
- EC Trade Negotiators and Industry Discuss How to ‘Re-Educate’ Public About Intellectual Property Rights (talk about employment)
- Witnesses at U.S. Trade Hearing Offer Opinions (and Warnings) on Intellectual Property in Upcoming Negotiations with the EU